Indications
After radiolabelling with sodium pertechnetate (99mTc) solution, the solution obtained is indicated for

Intravenous administration:

  • Bone marrow scanning (The product is not suitable to study the haematopoietic activity of the bone marrow.)
  • Inflammation scanning in areas other than the abdomen.

Subcutaneous administration:

  • Lymphoscintigraphy to demonstrate integrity of the lymphatic system and differentiation of venous from lymphatic obstruction.
  • Preoperative imaging and intraoperative detection of sentinel lymph nodes in melanoma, breast carcinoma, penile carcinoma, squamous cell carcinoma of the oral cavity and vulvar carcinoma.

Labelling activity
185 MBq – 5.5 GBq (5.0 mCi – 148.65 mCi)

Shelf life
18 months

Shelf-life and storage conditions after radiolabelling
8 hours, Do not store above 25°C.

Medi-RadioPharma is a long-established producer and distributor of radiopharmaceuticals, sealed radiation sources, and calibration standards for nuclear medicine, research, and industrial applications. With a portfolio covering diagnostic and therapeutic isotopes, generators, and custom-made radioactive preparations, Medi-RadioPharma serves hospitals, laboratories, and industrial partners across international markets.

Through its partnership with Van Overeem Nuclear B.V., Medi-RadioPharma enhances its service offering: Van Overeem’s Sources Made Easy concept provides customers with convenient multi-annual agreements for the delivery of new sources and the safe disposal of depleted ones, fully tailored to departmental needs.

Together, Medi-RadioPharma and Van Overeem Nuclear B.V. deliver a comprehensive, reliable solution for isotope supply, logistics, and lifecycle management — ensuring high-quality, compliant support for medical imaging, therapy, research, and industrial processes.